Shiraj Sen, MD, PhD

Tim Smith

Dr. Shiraj Sen is a medical oncologist and director of NEXT Oncology Dallas. Meeting some of the first individuals with cancer treated on modern immunotherapy clinical trials and watching them feel better and live longer after being told that there were no further standard treatments for them to receive motivated him to pursue a career in drug development in order …

Sharon T. Wilks, MD, FACP

Digital BTYcreative

Dr. Sharon T. Wilks is a valuable member of the Phase 1 Clinical Investigation Team. She focuses on research and advancement in the treatment of breast cancer with more than 32 years of research and clinical experience as a hematologist and medical oncologist. Dr. Wilks has been involved in breast cancer research since her early career in the Air Force. …

Ildefonso Ismael Rodriguez, M.D.

Digital BTYcreative

Medical Oncologist and Clinical Investigator Dr. Ildefonso Rodriguez specializes in hematology and medical oncology. He is also board-certified in internal medicine, hematology, and medical oncology. Dr. Rodriguez is also a Phase 1 clinical investigator. With a focus on hematology early in his career, he had made a shift to Phase I clinical research and trials to offer patients an opportunity …

Andrae Vandross, M.D.

Digital BTYcreative

Medical Oncologist   Dr. Andrae Vandross is trained, and board certified in medical oncology and internal medicine. He leads the Phase 1 clinical trial group at NEXT Oncology in Austin. Dr. Vandross is experienced in comprehensive and clear discussions with advanced cancer patients who are navigating the complex decisions associated with novel therapeutics. His highest priority is patient education in …

David Sommerhalder, M.D.

Digital BTYcreative

Medical Oncologist and Clinical Investigator   Dr. David Sommerhalder specializes in and is board certified in medical oncology and hematology and is also board certified in internal medicine. He works at NEXT Oncology San Antonio as an investigator on numerous clinical trials, where he helps to find additional treatment options for patients who otherwise may be out of options. He …